$纤维蛋白原(FGEN)$ 这也行我草。。。。。Data manipulation — changing data to make a drug look better than it is — is absolutely forbidden, as anyone at Novartis could tell you after the AveXis fiasco. And FibroGen CEO Conterno — named to his position 15 months ago following the sudden death of company founder Thomas Neff — still has considerable explaining to do.